SCHEMBL8989126

SCHEMBL8989126

COc1ccc(-c2ccc(C)c(CN3CCN(C(c4ccccc4)c4ccccc4)CC3)c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.48
▸ CACNA2D1 P54289 2/20 0.47
▸ CACNA1B Q00975 2/20 0.47
▸ CACNB1 Q02641 2/20 0.47
▸ CACNA1C Q13936 2/20 0.47
▸ CACNA1G O43497 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ CYP3A4 P08684 2/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ OPRD1 P41143 2/20 0.46
▸ OPRM1 P35372 1/20 0.46
▸ OPRK1 P41145 1/20 0.46
▸ OPRL1 P41146 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ SIGMAR1 Q99720 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ ATM Q13315 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7335540 0.91 LMNA (0.48) LMNAGAACYP3A4CYP2C19CYP2C9
SCHEMBL27463912 0.91 OPRD1 (0.53) LMNAGAACYP3A4CYP2C19CYP2C9
SCHEMBL7330964 0.88 CYP3A4 (0.58) LMNACACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL7336021 0.86 ACHE (0.60) LMNACACNA1BCACNA1GGAACYP3A4
SCHEMBL8989095 0.83 CYP2D6 (0.48) LMNACACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL7335379 0.83 DRD4 (0.60) LMNAGAACYP3A4CYP2C19OPRD1
Hydrochloric Acid SCHEMBL7326590 0.82 CYP2D6 (0.47) LMNACACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL16227069 0.77 KMT2A (0.61) LMNACYP3A4CYP2C19CYP2C9OPRD1
SCHEMBL7327529 0.76 SMN1; SMN2 (0.62) LMNACACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL7334983 0.74 MEN1 (0.60) LMNACACNA1BCYP2C19OPRD1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5545645-A Heterocyclic derivatives in the treatment of ischaemia and related diseases SYNTEX PHARMACEUTICALS, LIMITED (GB) 1996-08-13 — — US disclosed
US-5428037-A Piperazine derivatives; calcium and sodium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1995-06-27 — — US disclosed
Send feedback